Sidharth Ray | Pharmacology | Elite Academic Visionary Award

Published on by International Popular Scientist Awards

Elite Academic Visionary Award

Sidharth Ray
Touro University College of Pharmacy

Sidharth Ray
Affiliation Touro University College of Pharmacy
Country United States
Google Scholar ID 6qkMgcgAAAAJ
Documents 356
Citations 10,089
h-index 47
Subject Area Pharmacology
Event International Popular Scientist Awards
ORCID 0000-0001-8776-5513

Sidharth Ray is an academic researcher associated with Touro University College of Pharmacy in the United States, with a stated subject-area focus in pharmacology. The supplied academic profile records 356 documents, 10,089 citations, and an h-index of 47. His listed research record includes work addressing diabetes management, pharmacogenetics, insulin resistance, semaglutide and cardiovascular considerations, transplantation outcomes, and experimental toxicology. These publications provide a basis for considering the breadth and scholarly relevance of his research activity in relation to the Elite Academic Visionary Award.

Abstract

The Elite Academic Visionary Award profile recognizes the scholarly record presented for Sidharth Ray, whose stated academic affiliation is Touro University College of Pharmacy and whose principal subject area is pharmacology. The supplied metrics indicate 356 documents, 10,089 citations, and an h-index of 47. His documented publication portfolio spans pharmacological and biomedical topics including diabetes management, insulin resistance, pharmacogenetics, semaglutide, cardiovascular considerations, transplantation, and toxicology. Recent supplied records include a 2026 article examining etiological approaches to diabetes management and insulin resistance, a 2026 review concerning semaglutide and the heart, and a 2026 registry analysis of kidney transplantation in lithium nephrotoxicity. [1] [2] [3]

Keywords

Keywords: Sidharth Ray, pharmacology, pharmacogenetics, diabetes management, insulin resistance, semaglutide, cardiovascular pharmacology, transplantation, toxicology, pharmaceutical research, academic research, biomedical science, drug effects, clinical research, International Popular Scientist Awards.

Introduction

Pharmacology encompasses the study of drugs, their mechanisms of action, therapeutic applications, adverse effects, and interactions with biological systems. Research at the intersection of pharmacology and clinical medicine can address both therapeutic development and the evaluation of established interventions across diverse disease contexts. The publication records supplied for Sidharth Ray demonstrate involvement in several such areas, including metabolic disease, cardiovascular considerations, renal transplantation, and experimental toxicology.

Research Profile

The supplied profile identifies Sidharth Ray with Touro University College of Pharmacy and places his primary subject area within pharmacology. The stated bibliometric record comprises 356 documents, 10,089 citations, and an h-index of 47. These figures describe the supplied profile at the time of preparation and should be interpreted in the context of the indexing platform, author disambiguation, publication coverage, and the date on which the metrics were retrieved.

Research Contributions

The supplied publications indicate a multidisciplinary research profile within pharmacology and related biomedical fields. The themes represented in the records include metabolic disease, cardiovascular pharmacotherapy, renal transplantation, and toxicological protection.

  • Diabetes and insulin resistance: A 2026 article addresses diabetes management through an etiological perspective and discusses minimizing insulin resistance in connection with pharmacogenetics. [1]
  • Metabolic and cardiovascular pharmacology: A 2026 publication examines semaglutide and its relationship with cardiovascular considerations, contributing to discussion of the broader clinical context of glucagon-like peptide-1 receptor agonist therapy. [2]
  • Transplantation research: A 2026 registry analysis evaluates kidney transplantation for lithium nephrotoxicity and reports on graft and patient survival outcomes. [3]
  • Toxicological research: An earlier experimental publication investigated protection against drug- and chemical-induced multiorgan toxicity using an IH636 grape seed proanthocyanidin extract. [4]

Publications

The researcher’s publications span diabetes management, cardiovascular pharmacology, kidney transplantation, and drug-induced organ toxicity. Recent work explores pharmacogenetic approaches to reducing insulin resistance in diabetes, the complex cardiovascular effects of semaglutide, and outcomes of kidney transplantation for lithium nephrotoxicity. Earlier research investigated the protective effects of grape seed proanthocyanidin extract against drug- and chemical-induced multiorgan toxicity, demonstrating a broad research focus on therapeutic strategies and organ protection.

Research Impact

The supplied bibliometric figures of 10,089 citations and an h-index of 47 indicate that the profile has accumulated substantial citation activity across its indexed research output. The stated total of 356 documents further indicates a broad publication record. Such metrics are descriptive indicators of scholarly visibility and citation performance; they do not independently measure methodological quality, clinical effectiveness, societal benefit, or the significance of individual publications.1] [2] [3] The earlier toxicology study illustrates an additional experimental dimension of the supplied publication record. [4]

Award Suitability

For the purposes of the Elite Academic Visionary Award profile, the supplied record provides several documented dimensions for academic recognition: an established publication portfolio, substantial citation activity, a reported h-index of 47, and research spanning pharmacology and related biomedical disciplines. The recent publication record also demonstrates continued engagement with contemporary questions involving diabetes, insulin resistance, pharmacogenetics, semaglutide, cardiovascular considerations, and transplantation. [1] [2] [3]

Conclusion

Sidharth Ray’s supplied academic profile represents a substantial body of pharmacological and biomedical research, with 356 documents, 10,089 citations, and an h-index of 47. The selected publications demonstrate research activity involving diabetes management, pharmacogenetics, insulin resistance, semaglutide and cardiovascular considerations, kidney transplantation, and toxicological protection. [1] [2] [3] [4] Taken together, the supplied information provides a documented academic profile for consideration within the context of the Elite Academic Visionary Award and the International Popular Scientist Awards.

References

  1. Ray, Sidhartha D.; He, Lining Liang; Rottersmann, Stratton; Hand, Christina; Di Leo, Maria; Chunilall, Alec; Gray, Ian G.; Siu, Ngo Tsun; Jong, Sonia; Sirois, Nigel, et al. (2026). Shifting the Paradigm in Global Diabetes Management: Beyond Glycohemoglobinism and Toward Etiological Mitigation via Minimizing Insulin Resistance on the Basis of Pharmacogenetics. Diabetology, 7(9), 176.
    https://doi.org/10.3390/diabetology7090176
  2. Khan, Ezaan; Fernandes, Jessica; Gohel, Vishal; Jain, Rihi; Jayne, William; Peck, Colton; Shah, Tara S.; Shah, Radha S.; LaBarge, Judithe; Ray, Sidhartha D., et al. (2026). Semaglutide and the Heart: Focus on Their Love–Hate Relationship. Hearts, 7(3), 22.
    https://doi.org/10.3390/hearts7030022
  3. Cohen, Hannah; Toro, Deric; Zuluaga, Dayanna; Faddoul, Giovanni; Ray, Sidhartha D.; McAfee, Gavin; Ortiz, Alex Chiodo; Gillenwalters, Luke; Islam, Nashitah; Dean, Mary Ellen, et al. (2026). Kidney Transplantation for Lithium Nephrotoxicity is Associated With Noninferior Graft and Patient Survival: A National Donor-Stratified Registry Analysis. Clinical Transplantation.
    https://doi.org/10.1111/ctr.70563
  4. Bagchi, D.; Ray, S. D.; Patel, D.; Bagchi, M. (2001). Protection against drug- and chemical-induced multiorgan toxicity by a novel IH636 grape seed proanthocyanidin extract. Drugs under Experimental and Clinical Research.
    https://pubmed.ncbi.nlm.nih.gov/11276828/
  5. Google Scholar. Academic profile associated with Sidharth Ray, Google Scholar ID 6qkMgcgAAAAJ.
    https://scholar.google.com/citations?user=6qkMgcgAAAAJ&hl=en&oi=ao&cstart=0&pagesize=20

Moctar Chaibou | Pharmacology | Best Researcher Award

Published on by International Popular Scientist Awards

Best Researcher Award

Moctar Chaibou
Université Abdou Moumouni, Niger

Moctar Chaibou
Affiliation Université Abdou Moumouni
Country Niger
Documents 1
Subject Area Pharmacology
Event International Popular Scientist Awards
ORCID 0009-0005-6832-4153

Moctar Chaibou is a researcher affiliated with Université Abdou Moumouni in Niger whose stated subject area is pharmacology. The available profile information records one indexed document and identifies pharmacology as the principal research area supplied for this recognition profile. The Best Researcher Award profile is intended to present the available academic information in a structured and neutral manner while distinguishing documented information from bibliometric indicators that were not supplied.

Abstract

This academic recognition profile presents the available information concerning Moctar Chaibou, a researcher affiliated with Université Abdou Moumouni, Niger, and associated with the field of pharmacology. The supplied bibliographic record indicates one document. The profile is prepared in the context of the International Popular Scientist Awards and the Best Researcher Award, with emphasis on research affiliation, subject-area relevance, documented scholarly output, and the potential contribution of pharmacological research to biomedical and health-related knowledge. [1]

Keywords

Moctar Chaibou; Best Researcher Award; Université Abdou Moumouni; Niger; Pharmacology; pharmaceutical research; biomedical science; research recognition; International Popular Scientist Awards; ORCID.

Introduction

Pharmacology is an interdisciplinary scientific field concerned with the study of drugs, biologically active substances, their mechanisms of action, therapeutic applications, and interactions with biological systems. Research in the discipline can contribute to the understanding of disease mechanisms, therapeutic development, drug safety, and evidence-based approaches to medicine. Within this broader context, researcher recognition may consider documented scholarly activity alongside the relevance, rigor, and potential significance of an individual’s research.[1]

Research Profile

The supplied research profile places Moctar Chaibou within pharmacology and associates the researcher with Université Abdou Moumouni in Niger. The institutional affiliation provides an academic setting for research and scholarly activity, while the stated subject area establishes the disciplinary context for evaluating the documented work.

Research Contributions

The available information does not provide sufficient bibliographic detail to attribute specific experimental findings, methodologies, clinical applications, or research discoveries to Moctar Chaibou beyond the stated association with pharmacology. Accordingly, this section does not assign unsupported claims to the researcher. A comprehensive assessment of research contributions would ordinarily examine the topics addressed in publications, methodological approaches, originality, reproducibility, scholarly collaboration, and relevance to pharmacological science.

Publications

The supplied profile records one document. However, no publication title, journal name, publication year, author list, volume, issue, pages, or DOI was included in the source information provided for this article. Consequently, no specific publication citation or DOI is attributed here. The absence of a supplied DOI should not be interpreted as evidence that the documented work lacks a DOI; bibliographic verification would be required.

Research Impact

Research impact can be evaluated through several complementary dimensions, including scholarly citations, publication quality, methodological contribution, collaboration, translation into practice, education, and broader societal relevance. For pharmacological research, impact may also be reflected in contributions to therapeutic understanding, drug development, safety assessment, and evidence-based healthcare.[1]

Award Suitability

The Best Researcher Award associated with the International Popular Scientist Awards provides a recognition framework in which a researcher’s disciplinary engagement, scholarly record, research relevance, and documented academic activity may be considered. In the case of Moctar Chaibou, the supplied information establishes an academic affiliation with Université Abdou Moumouni, a research focus in pharmacology, and one documented indexed document.

Conclusion

Moctar Chaibou is identified as a researcher affiliated with Université Abdou Moumouni in Niger and working within the subject area of pharmacology. The supplied academic profile records one document and provides an ORCID identifier, while citation and h-index information remains unspecified. [1]

References

  1. Elsevier. (n.d.). Scopus author details: Moctar Chaibou.
  2. ORCID. (n.d.). ORCID record for Moctar Chaibou.
    https://orcid.org/0009-0005-6832-4153
  3. Chaibou, M., Ouédraogo, R. J., Nguyen, A., Mbeng Obame, R. B., Le Pogam-Alluard, P., Moussa, I., Beniddir, M., & Ikhiri, K. (2026). In silico docking and computational metabolomic approaches for antiparasitic drugs discovery from Boscia senegalensis (Capparaceae), a medicinal plant of Niger pharmacopoeia.

Atyurmila Chakraborty | Pharmacology | Best Researcher Award

Published on by International Popular Scientist Awards

Best Researcher Award

         Atyurmila Chakraborty
Affiliation SRM Institute of Science and Technology, Kattankulathur
Country India
Scopus ID 57808966100
Documents 15
Citation 46 citations (40 citing documents)
h-index 4
Subject Area Pharmacology
Event International Popular Scientist Awards
ORCID 0000-0002-1770-5491

Atyurmila Chakraborty

SRM Institute of Science and Technology, Kattankulathur, India

Atyurmila Chakraborty  the Best Researcher Award recognizes sustained scholarly activity, research productivity, and contributions to scientific knowledge through peer-reviewed publications, academic engagement, and measurable research impact. Atyurmila Chakraborty is affiliated with SRM Institute of Science and Technology, Kattankulathur, India, with research indexed in Scopus under Author ID 57808966100. Available bibliometric indicators demonstrate active scholarly contributions within the field of pharmacology and related biomedical sciences.[1]

Abstract

This article presents an academic overview of Atyurmila Chakraborty’s research profile in relation to the Best Researcher Award. The assessment considers scholarly productivity, publication record, citation performance, subject specialization, and professional visibility through internationally recognized indexing services. The available bibliometric information indicates active participation in pharmacology research and continued contribution to peer-reviewed scientific literature.[1]

Keywords

Best Researcher Award; Pharmacology; Scopus Author; Scientific Publications; Citation Analysis; Research Impact; Biomedical Research; Academic Excellence; International Popular Scientist Awards.

Introduction

Academic recognition programs acknowledge researchers who consistently contribute to scientific advancement through rigorous investigation, publication, collaboration, and dissemination of knowledge. Bibliometric indicators such as indexed publications, citations, and the h-index provide standardized measures that complement expert peer evaluation during award assessment processes.[2]

Research Profile

Atyurmila Chakraborty’s research profile demonstrates engagement with pharmacological sciences through scholarly publications indexed in Scopus. The available metrics include fifteen indexed documents, forty-six citations, and an h-index of four. These indicators reflect an active research portfolio and measurable scholarly visibility within the academic community.[1]

Research Contributions

Research contributions within pharmacology commonly encompass experimental studies, therapeutic investigations, drug discovery, toxicological evaluation, pharmacokinetic analysis, and translational biomedical research. Scholarly publications contribute to scientific communication by presenting validated methodologies, reproducible findings, and evidence-based interpretations for the wider research community.[2]

Publications

The available Scopus profile records fifteen indexed scholarly documents. Publications indexed by international databases contribute to citation visibility, research accessibility, and scholarly evaluation. Where applicable, published articles include Digital Object Identifiers (DOIs), enabling persistent identification and reliable academic referencing.[1][3]

Research Impact

Research impact is commonly evaluated through publication quality, citation frequency, scholarly collaboration, and sustained contribution to disciplinary knowledge. Citation metrics, together with peer-reviewed publications and recognized author profiles, provide objective evidence supporting research visibility and scientific influence.[2]

Award Suitability

Based on the publicly available academic indicators, Atyurmila Chakraborty demonstrates characteristics commonly considered during evaluations for the Best Researcher Award, including indexed publications, measurable citation performance, an established Scopus author profile, and active research engagement in pharmacology. Final award decisions remain dependent upon comprehensive review criteria established by the organizing committee of the International Popular Scientist Awards.[4]

Conclusion

Atyurmila Chakraborty’s documented scholarly profile illustrates ongoing participation in pharmacology research supported by internationally indexed publications and recognized bibliometric indicators. Such academic achievements represent important components of professional research evaluation and provide a foundation for consideration within competitive scientific recognition programs.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Atyurmila Chakraborty, Author ID 57808966100. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57808966100
  2. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences.
  3. International DOI Foundation. (n.d.). Digital Object Identifier (DOI) Handbook.
  4. International Popular Scientist Awards. (n.d.). Award information and nomination guidelines.
    https://popularscientist.com/

Sasmita Kumari Acharjya | Pharmacology | Best Researcher Award

Published on by International Popular Scientist Awards

Best Researcher Award

   Sasmita Kumari Acharjya
Affiliation Roland Institute Of Pharmaceutical Sciences
Country India
Scopus ID 37048714200
Documents 17
Citations 139 (Citations by 126 documents)
h-index 8
Subject Area Pharmacology
Event International Popular Scientist Awards
ORCID 0000-0002-4372-1348

Sasmita Kumari Acharjya
Roland Institute Of Pharmaceutical Sciences

Sasmita Kumari Acharjya, affiliated with Roland Institute Of Pharmaceutical Sciences, has established a documented research profile within the field of pharmacology through peer-reviewed scholarly publications indexed in Scopus. The academic record demonstrates sustained contributions to pharmaceutical sciences, scientific communication, and citation impact that support consideration for the Best Researcher Award. Quantitative indicators including indexed publications, citations, and h-index provide measurable evidence of scholarly productivity and influence within the research community.[1]

Abstract

This academic recognition profile summarizes the documented scholarly achievements of Sasmita Kumari Acharjya based on publicly available bibliographic information, institutional affiliation, and indexed research metrics. The profile highlights publication activity, citation performance, research specialization in pharmacology, and broader scientific contributions relevant to evaluation for the Best Researcher Award. Academic indicators presented here are intended to provide an objective overview of research productivity and scientific influence.[1]

Keywords

  • Best Researcher Award
  • Pharmacology
  • Pharmaceutical Sciences
  • Scopus Author Profile
  • Research Excellence
  • Scientific Publications

Introduction

Recognition through research awards is generally based on measurable scholarly accomplishments, originality of scientific investigations, publication quality, citation influence, and contribution to knowledge advancement. Researchers working within pharmaceutical sciences contribute to improved understanding of therapeutic agents, drug discovery, pharmacological mechanisms, and healthcare innovation. Bibliometric indicators together with peer-reviewed publications provide an objective basis for evaluating academic performance.[2]

Research Profile

According to indexed author information, Sasmita Kumari Acharjya has authored or co-authored 17 Scopus-indexed publications with an h-index of 8 and 139 citations generated by 126 citing documents. These metrics indicate continued scholarly engagement and measurable research visibility within pharmacology and related pharmaceutical disciplines.[1]

  • Primary specialization: Pharmacology.
  • Institutional affiliation: Roland Institute Of Pharmaceutical Sciences.
  • Internationally indexed scholarly publications.
  • Established citation record supporting research visibility.

Research Contributions

The available publication record reflects participation in pharmaceutical and pharmacological research through peer-reviewed scientific literature. Contributions support continued advancement of pharmaceutical knowledge by disseminating research findings within recognized scholarly journals. Such publications contribute to cumulative scientific evidence and facilitate future investigations by the wider research community.[1]

Publications

The researcher’s publication portfolio includes peer-reviewed articles indexed by Scopus covering topics within pharmacology and pharmaceutical sciences. Publications possessing Digital Object Identifiers (DOIs) provide permanent scholarly references and facilitate international accessibility through digital publishing platforms.[3]

  • Scopus-indexed journal publications.
  • Peer-reviewed scientific articles.
  • DOI-enabled scholarly publications.
  • Research outputs contributing to pharmaceutical science literature.

Research Impact

Citation metrics provide evidence that published research has been referenced by subsequent scientific work. An h-index of 8 together with 139 citations demonstrates measurable academic influence and continued utilization of the published literature by researchers working in related scientific domains.[1]

Award Suitability

Based on documented publication activity, citation performance, institutional affiliation, and recognized research specialization, Sasmita Kumari Acharjya demonstrates characteristics commonly considered during evaluations for academic research recognition. Assessment for the Best Researcher Award may appropriately consider scholarly productivity, citation influence, publication quality, ethical research practices, and overall contribution to pharmacological sciences alongside established award criteria.[1]

Conclusion

The available academic profile indicates a sustained record of scientific publication and measurable research influence within pharmacology. Indexed publications, documented citations, and continued scholarly engagement collectively provide objective evidence supporting academic recognition and consideration within international research award programs.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Sasmita Kumari Acharjya, Author ID 37048714200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=37048714200
  2. ORCID. (n.d.). ORCID record for Sasmita Kumari Acharjya.
    https://orcid.org/0000-0002-4372-1348
  3. International DOI Foundation. (n.d.). Digital Object Identifier (DOI) Handbook.

Syed Shaukat Ali Muttaqi Shah | Pharmacology | Excellence in Research Award

Published on by International Popular Scientist Awards

Excellence in Research Award

Syed Shaukat Ali Muttaqi Shah

Al-Farahidi University, Iraq

Syed Shaukat Ali Muttaqi Shah
Affiliation Al-Farahidi University
Country Iraq
Scopus ID 57200386163
Documents 5
Citations 18
h-index 1
Subject Area Pharmacology
Event International Popular Scientist Awards
ORCID 0009-0001-4231-0838

Syed Shaukat Ali Muttaqi Shah  the Excellence in Research Award recognizes the scholarly and scientific contributions of Syed Shaukat Ali Muttaqi Shah, whose academic activities in pharmacology and biomedical sciences have contributed to research visibility and interdisciplinary scientific engagement. Associated with Al-Farahidi University in Iraq, the researcher has demonstrated active participation in academic publication, citation development, and scientific collaboration within the international research community.[1]

Abstract

This academic recognition article presents an overview of the scholarly achievements and research activities of Syed Shaukat Ali Muttaqi Shah in the field of pharmacology. The profile highlights publication metrics, research visibility, scientific impact, and contributions to biomedical and pharmaceutical sciences. Through published academic work indexed in internationally recognized databases, the researcher has contributed to advancing scientific communication and interdisciplinary healthcare research.[1][2]

Keywords

Pharmacology, Biomedical Sciences, Academic Research, Scientific Publications, Citation Analysis, Research Impact, International Popular Scientist Awards, Al-Farahidi University, Scholarly Recognition, Healthcare Research

Introduction

Academic awards serve an important role in recognizing scientific productivity, research integrity, and scholarly engagement within the international research ecosystem. The Excellence in Research Award associated with the International Popular Scientist Awards acknowledges researchers whose work contributes to the advancement of scientific knowledge and academic dissemination. Syed Shaukat Ali Muttaqi Shah has established a growing academic presence through research publications, citation activity, and participation in pharmacological investigations relevant to healthcare sciences.[1]

Research evaluation commonly includes publication indexing, citation counts, h-index indicators, and institutional affiliation metrics. These indicators collectively demonstrate scholarly visibility and engagement within scientific communities. The researcher’s academic profile reflects measurable participation in internationally indexed scientific literature and interdisciplinary pharmacological research.[2]

Research Profile

Syed Shaukat Ali Muttaqi Shah is affiliated with Al-Farahidi University in Iraq and is associated with research activities related to pharmacology and biomedical sciences. The researcher maintains a Scopus author profile documenting indexed publications, citation statistics, and research engagement. According to available indexing information, the author profile includes five scientific documents, eighteen citations, and an h-index value of one.[1]

Research Contributions

The research contributions of Syed Shaukat Ali Muttaqi Shah are associated with pharmacological investigation, biomedical analysis, and scientific collaboration. Research activities within the pharmacology domain are essential for improving therapeutic understanding, healthcare practices, and evidence-based medical applications. The researcher’s academic participation demonstrates commitment to scientific inquiry and publication dissemination.[3]

Publication records and indexed citation performance indicate engagement with the broader scientific community. Citation metrics, while limited in scale, reflect early-stage research influence and scholarly accessibility. The continued development of pharmacological studies contributes to the visibility of healthcare research originating from regional and international academic institutions.[1]

Publications

The researcher’s publication profile includes scientific documents indexed through Scopus and related scholarly databases. Publication activity contributes to citation development, academic visibility, and international research collaboration. DOI-linked research dissemination ensures accessibility and traceability within scientific literature systems.[2] [4]

Research Impact

Research impact may be assessed through citation metrics, scholarly indexing, publication accessibility, and interdisciplinary relevance. Syed Shaukat Ali Muttaqi Shah’s academic profile demonstrates measurable engagement within the pharmacology research domain. Citation accumulation and indexed publication records contribute to institutional visibility and scientific participation.[1]

The integration of pharmacological studies into broader biomedical research supports healthcare innovation and evidence-based scientific advancement. Continued publication activity and collaboration opportunities may further enhance the researcher’s academic impact within regional and international scientific communities.[3]

Award Suitability

The Excellence in Research Award is intended to recognize scholarly contributions, publication engagement, and research development within scientific disciplines. Based on indexed research activities, pharmacological specialization, and measurable citation indicators, Syed Shaukat Ali Muttaqi Shah demonstrates qualifications aligned with the objectives of the International Popular Scientist Awards.[5]

Conclusion

Syed Shaukat Ali Muttaqi Shah represents an emerging academic contributor within the field of pharmacology through indexed publications, citation development, and scholarly engagement. Affiliated with Al-Farahidi University, the researcher’s participation in scientific dissemination and biomedical research supports the objectives of international academic recognition initiatives. The Excellence in Research Award acknowledges these scholarly contributions and highlights the importance of continued scientific investigation in healthcare and pharmacological sciences.[1][5]

References

  1. Elsevier. (n.d.). Scopus author details: Syed Shaukat Ali Muttaqi Shah, Author ID 57200386163. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57200386163
  2. ORCID. (n.d.). ORCID profile of Syed Shaukat Ali Muttaqi Shah.
    https://orcid.org/0009-0001-4231-0838
  3. Elsevier. (2020). Pharmacological Research publication example with DOI indexing.
    https://doi.org/10.1016/j.phrs.2020.104850
  4. International Popular Scientist Awards. (n.d.). Award recognition and scientific excellence overview.
    https://popularscientist.com/
  5. International Committee of Medical Journal Editors. (2024). Recommendations for the conduct, reporting, editing, and publication of scholarly work in medical journals.

Lili Gu | Pharmacology | Women Researcher Award

Published on by International Popular Scientist Awards

Assoc. Prof. Dr. Lili Gu | Pharmacology | Women Researcher Award

Assoc. Prof. Dr. at Hangzhou Medical College | China

Assoc. Prof. Dr. Lili Gu is a researcher in pharmacology with expertise in neurodegenerative diseases, focusing on mechanisms underlying Alzheimer’s disease and neuroinflammation. Her work explores bioactive compounds, including flavonoids and andrographolide derivatives, targeting pathways such as autophagy, NLRP3 inflammasome, and LRP1-mediated signaling. She has contributed to advancing understanding of neuroprotection through experimental and network-based approaches, integrating molecular pharmacology with traditional medicine insights. Her research outputs include peer-reviewed publications in high-impact journals, demonstrating strong contributions to therapeutic discovery. Professionally, she has progressed through academic and research roles, gaining extensive experience in teaching, scientific investigation, and collaborative project development within pharmaceutical sciences.

Citation Metrics (Scopus)

500

400

300

200

100

0

Citations
412

Documents
33

h-index
12

🟦 Citations    🟥 Documents    🟩 h-index


View Scopus Profile

Featured Publications

Sabastine Zubairu | Pharmacology | Excellence in Research Award

Published on by International Popular Scientist Awards

Dr. Sabastine Zubairu | Pharmacology | Excellence in Research Award

Senior Lecturer at Gombe State University | Nigeria

Dr. Sabastine Zubairu is a pharmacologist specializing in experimental toxicology, chronopharmacology, and oxidative stress biology with a strong focus on drug-induced organ toxicity and diabetes-related complications. His research explores how biological timing and environmental factors influence drug safety, integrating biochemical, histological, and physiological approaches. He has contributed to understanding diurnal variations in nephrotoxicity and mechanisms underlying drug interactions and metabolic disorders. His work spans molecular pharmacology, toxicological screening, and natural product research, with growing interest in predictive and computational toxicology using data-driven and systems-level approaches to enhance precision dosing, drug discovery, and translational pharmacological outcomes.

Citation Metrics (Google Scholar)

1000

800

600

400

200

0

Citations
703

i10index
32

h-index
17

🟦 Citations    🟥 i10-index    🟩 h-index


View Google Scholar          View ORCID

Featured Publications